0000950170-24-028808.txt : 20240308 0000950170-24-028808.hdr.sgml : 20240308 20240308173813 ACCESSION NUMBER: 0000950170-24-028808 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20240306 FILED AS OF DATE: 20240308 DATE AS OF CHANGE: 20240308 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: SIEGALL CLAY B CENTRAL INDEX KEY: 0001167496 ORGANIZATION NAME: FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 001-39593 FILM NUMBER: 24735783 MAIL ADDRESS: STREET 1: 21823 30TH DR SE CITY: BOTHELL STATE: WA ZIP: 98021 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: Shattuck Labs, Inc. CENTRAL INDEX KEY: 0001680367 STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834] ORGANIZATION NAME: 03 Life Sciences IRS NUMBER: 812575858 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: 500 W. 5TH STREET CITY: AUSTIN STATE: TX ZIP: 78701 BUSINESS PHONE: 512-900-4690 MAIL ADDRESS: STREET 1: 500 W. 5TH STREET CITY: AUSTIN STATE: TX ZIP: 78701 4 1 ownership.xml 4 X0508 4 2024-03-06 0001680367 Shattuck Labs, Inc. STTK 0001167496 SIEGALL CLAY B C/O SHATTUCK LABS, INC. 500 W. 5TH STREET, SUITE 1200 AUSTIN TX 78701 true false false false false Stock Option (Right to Buy) 9.47 2024-03-06 4 A false 33409 0.00 A 2034-03-06 Common Stock 33409 33409 D This option represents the right to purchase a total of 33,409 shares of the Issuer's common stock, and vests in three equal annual installments on each of the first three anniversaries of March 1, 2024, subject to the Reporting Person's continued service to the Issuer. /s/ Andrew R. Neill, Attorney-in-Fact for Clay B. Siegall 2024-03-08